Karen Rosenberg, Andrea Kayyali
According to this study:
* The shape and color of pills commonly prescribed to patients after myocardial infarction often differ according to the manufacturer. Such changes increase the likelihood that patients will discontinue use of their prescribed medications.
* Patients’ stopping their treatment can lead to significant morbidity or even death.
© 2001-2025 Fundación Dialnet · Todos los derechos reservados